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In much the same way as the survival of many species depends upon their abundant 
production of such genetic materials as pollens and spermatozoa, so does scientific progress 
depend upon a continual, lavish production of basic scientific works. In stimulating, 
assembling, and disseminating various scientific studies related to the skin, the Montagna 
Symposia on the Biology of Skin have ensured progress not only in the understanding and 
management of skin diseases but in the discovery of widely applicable facts and laws. For the 
skin was, is, and probably always will be one of the richest sources of basic biologic 
information. 
No scientific discovery is wasted, no accurate clinical observation useless. No one can 
foresee when or how some seemingly irrelevant discovery in pure science or some seemingly 
insignificant clinical observation will yield fruits of incalculable practicable value. We cite 
here a few examples of some of the best results from apparently unrelated research and 
isolated clinical findings. In dermatologic research, the circular rhythm from patient with 
cutaneous disease to laboratory and from laboratory back to patient creates a centrifugal 
force that often spins off valuable discoveries. 
The title of this manuscript indicates that it is 
not a final summation and pronouncement, but an 
epilogue as prologue. For what has been contrib-
uted by the participants in these symposia is just a 
beginning. We must look into the future to discern 
something of the impact and importance of the 
contri butions. 
Late in May of 1975 on Cape Cod when this 
manuscript was being prepared, the scrub pines 
were beginning to shed their pollen. Every puff of 
wind sprayed the fine golden dust into the air, 
covering the house, gaining entry through every 
crack and cranny, gilding the furniture, getting 
into our hair, noses, ears, clothes, and utensils. 
Tiny golden grains, finer than flour, billions and 
billions of them, covered people and animals, 
plants and objects. 
There was a temptation to exclaim: How profli-
gate of Nature! But just imagine what would 
happen if everyone of those grains of pollen had 
;'eached its goal and produced a new pine tree. In a 
: hort time, no space would be left on earth for any 
lther living creature. If all the sixteen million eggs 
md all the descendants of just one fertilized oyster 
mrvived and produced adults, in a few years oyster 
;hells alone would exceed the weight of the entire 
;arth! And how many spermatozoa are wasted in 
1 uman ejaculates before one reaches and fertilizes 
·m ovum? 
These seeming excesses of Nature are necessary. 
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Given the dangers and enemies that confront most 
species, the precarious balance of survival would 
be tipped toward extinction without such overabun-
dance of genetic material. These are but a few 
examples of Nature's fail-safe munificence. 
There are some resemblances between the need 
for Nature's lavish production of genetic material 
and the need for the continual production of large 
numbers of investigations in basic sciences. Only a 
small fraction of the scientific research that goes on 
can yield direct results of discernible, immediate, 
practical value. And no one can predict which work 
will be fertile, nor when nor how. No one can 
predict when some finding of pure science, seem-
ingly remote from any practical application, will 
bear fruit. 
Certain inferences can be drawn from these 
contemplations. Without large numbers of scien-
tific studies, the outlook for biomedical advance 
would be dim, just as without the overprocluction 
of genetic material the pines, the oysters, and the 
human race would be in danger of extinction. 
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The Symposia on the Biology of Skin help to 
ensure that enough accurate and diversified basic-
science genetic material is being produced and 
disseminated to guarantee practical advances in 
the understanding of the skin and in the preven-
tion and management of its diseases. And that is 
the name of the game. No matter how much we 
profess our dedication to pure science; no matter 
how elated we are by our puzzle solving; no matter 
how much ego satisfaction we derive from the 
beautiful experimental data we produce to support 
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our brilliant guesses and hypotheses, we are all 
inspired and supported by the vision of ultimate 
clinical application of our findings. 
Each practical advance, whether derived di-
rectly or remotely from some scientific discovery, 
can be of incalculable value to mankind and to the 
world. Fudenberg [1], utilizing the method of Rice 
[2], attempted to compute the monetary value of 
certain benefits deriving from basic research. He 
selected areas in which the products of research 
have been applied to the treatment or prevention 
of disease and to the introduction of new therapeu-
tic or diagnostic methods. He cites the basic work 
of John Enders which led to the in vitro growth of 
virus in monkey tissue cultures, which in turn led 
to the development of polio vaccine and the 
eventual prevention of this disease. This applica-
tion alone saved the American public over 6 billion 
dollars during the period 1955-1961 and relieved 
the suffering and banished the fear of polio from 
the minds of millions of parents. 
Selman Waxman's original work on strep-
tomycin, which signaled the development of one of 
the most effective agents for the treatment of 
tuberculosis, provided benefits of inestimable 
value. The scientific experiments on feed-back 
control of antibody synthesis yielded incalculable 
rewards through the near eradication of hemolytic 
disease in the newborn by the administration of 
small doses of anti-Rh globulin to Rh-negative 
women. Another example of the rewards of basic 
research is the UV irradiation of infants to prevent 
kernicterus. 
Fundenberg further suggests that the develop-
ment of measles vaccine and the discovery of a way 
to detect the presence of serum hepatitis virus in 
certain blood donors will each save about 100 
million dollars a year. Although some economists 
believe that the Rice approach is not theoretically 
correct, it is still one of the best ways to obtain 
actual numbers and some estimates of the enor-
mous economic savings that result from govern-
mental expenditures on research. Even if the 
figures are only rough approximations, they indi-
cate the magnitude of the returns from dispropor-
tionately small investments in scientific research. 
There is probably no such thing as a completely 
wasted basic scientific discovery. Nor is any clini-
cal observation likely to be unfruitful , provided it 
is new and accurate. For both the scientific and 
practical advances of today are built upon the 
legions of unseen and unremembered discoveries 
and clinical findings that preceded them-just as 
the coral atoll, which emerges from the sea in all its 
beauty and usefulness, exists only because of the 
billions of unseen, minuscule creatures whose re-
mains support it. 
There are many exam pIes of seemingly remote 
laboratory discoveries that yielded undreamed of 
practical fruits. Similarily, many clinical observa-
tions lead to unsuspected, apparently unrelated 
scientific advances. 
Let us submit a few examples and dwell on how 
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the reciprocal stimuli-from patient to laboratory, 
from laboratory to patient-furnish a circular 
rhythm whose momentum and centrifugal force 
spin off medical progress. 
Richard Gubner's seemingly chance discovery 
(1951) that the antimetabolites produce remissions 
of psoriasis could not have been made without the 
preceding work on the biochemistry of the nucleic 
acids, of aminopterin and related drugs. It is 
unlikely that the demonstration of the accelerated 
psoriatic cell cycles and their arrest in different 
phases would have come as quickly as it did 
without the stimulus from Gubner's clinical obser-
vation. The recent introduction by Parrish, Fitzpa-
trick, Wolff, and their co-workers of a treatment for 
psoriasis that uses the systemic administration of 
8-methoxypsoralen and external exposure to ul-
traviolet A (that is, UV rays of between 320 and 400 
nm) provides a striking illustration of how vera-
cious clinical observations can combine with scien-
tific findings and scientific thinking to produce 
medical and economic benefits. Several thousand 
years ago, unknown Egyptians introduced skin 
therapy that used photosensitization by the psoral-
en-containing plant, Ammi majus Linn. They 
could not dream that eons later their clinical and 
empiric discoveries would lead to a promising 
modification of the therapy of psoriasis. 
Years ago at the Dermatologic Clinic at the 
University of Zurich, Bruno Bloch, Guido Mie-
scher, Sam Peck, and Sam Becker, Sr. sought to 
discover dopa-positive cells in every human organ, 
taken from the youngest fetus to the oldest person. 
They searched assiduously, and minutely and 
conscientiously reported their findings of the en-
zyme-containing cells. They reported them not 
only in the skin but also in the retina and in other 
neurologic tissues such as the basal ganglia, the 
substantia nigra, and the meninges. They had no 
idea of the function of the dopa-oxidase enzyme in 
these cells nor did they or anyone else at that time 
dream that some day dopamine would be linked to 
important functions of the neurologic system and 
that levo-dopa would become a therapeutic agent 
in parkinsonian syndromes. 
Could Joseph Jadassohn and his school foresee 
that their observations on skin anergy in such 
diseases as sarcoidosis, leprosy, Hodgkin's disease, 
and granuloma fungoides would someday be con-
nected with immune deficiency states and with 
T-cell abnormalities? With all their vision, Land-
steiner and Jacobs, Chase, and the other workers in 
skin sensitization to chemicals such as dinitro-
chlorobenzene could not have guessed that this 
skin sensitivity or its absence would be useful in 
the study of immunodeficiencies. 
How could Rostenberg and Sulzberger, col-
laborating with Landsteiner on dinitrochloroben-
zene sensitization in the 1930s [3], foresee that 
many years later Baer and Rosenthal [4] would 
show that dichloronitrobenzene, a chemical rela-
tive of dinitrochlorobenzene, could confer resist-
ance to sensitization by that allergen but be unable 
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to sensitize or to elicit allergic reactions? Even in 
their wildest imaginings Calmette and Guerin 
could not have predicted that their bacillus would 
be used to treat malignancies. 
And wouldn't the Suttons, pere et fils, have been 
amazed if they had foreseen that their observations 
on the halo nevus would someday form a link in the 
chain of reasoning that points to immunologic 
forces at work in melanoma and in the therapy and 
regression of melanomas and other cancers? 
When the Viennese pediatrician Carl Leiner 
reported in 1908 that infants with the disease he 
named erythrodermia desquamativa improved 
when they were shifted from the mother's breast to 
bottle feeding or to the breast of a wet nurse, could 
he have foreseen that this would lead to the 
discovery that cow's milk is a rich source of the C5 
fraction of complement, a complement fraction 
that these babies lacked and needed? And the idea 
that their studies of the complement cascade 
would some day lead to a better understanding of 
Leiner's disease and would perhaps provide a 
therapeutic tool for this sometimes lethal der-
matosis was surely remote from the minds of 
laboratory investigators bent on separating the 
immunologic pieces of complement. 
Studies with prostaglandins provide an impres-
sive example of the circular rhythm, centrifugal 
force, and spin-off we have mentioned. "Prosta-
glandins" was the name given by von Euler and 
Goldblatt to certain chemical mediators in the 
accessory sex glands and in seminal fluid in the 
belief that they were characteristic products of the 
prostate gland. Some of these long-chain fatty 
acids, prostaglandin E2 and prostaglandin F 2a, are 
among the chemical mediators which produce skin 
inflammation like that which results from expo-
sure to ultraviolet rays. Aspirin, indomethacin, 
and other anti-inflammatory drugs inhibit the 
formation of these prostaglandins. Thus, the 
widely dissimilar studies of van Euler, Goldblatt, 
Finsen, Miller; of Diane Snyder in Harvey Blank's 
department; and of dermatologists including Mal-
colm Greaves and co-workers, Lawrence Solomon, 
Eaglston, J. Graham Smith, Jr., and Juhlin com-
bined to shed the first bright light on how that 
ancient, mysterious, marvelously effective drug, 
aspirin, reduces all manner of inflammation and 
allays pain. 
We have purposely omitted citing the numerous 
examples of how sometimes a lucky chance leads to 
valuable discoveries. These and Pasteur's com-
ment that "chance favors only the prepared mind" 
are too well known to require elaboration [5]. 
Our examples were chosen mainly because they 
are related to dermatology and are, therefore, 
among those with which we happen to be most 
familiar. These examples clearly illustrate a point 
even more significant than the fact that no one can 
foretell the future impact of any new observation. 
Among all the specialties of medicine, dermatology 
is the one most likely to succeed, both in supplying 
clinical questions that lead to scientific advances 
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and in supplying answers to basic scientific ques.: 
tions. Studies of, studies on, and studies in the 
human skin have been incomparably fertile in 
these respects. No other organ has offered equal 
opportunities in the past; no other organ offers 
such unique opportunities today; and it is unlikely 
that any organ will offer better opportunities in the 
future. Each of the participants in the Symposia 
on the Biology of Skin has contributed something 
with almost limitless possibilities for advancing 
scientific knowledge and for furthering progress in 
medicine's fight against disease. It is the immeas-
urable contribution of the past symposia that they 
have assembled, integrated, and disseminated the 
diverse investigations that have one thing in com-
mon: they are all derived from, or applicable to, 
the skin and its diseases. And that, too, augurs 
exciting progress for the future Symposia on the 
Biology of Skin. 
It is impossible to estimate the dollar savings 
and health benefits that have been derived and will 
accrue from such stimuli. Valuable benefits will 
accrue, directly or indirectly, from the bringing 
together of young dermatologists and basic scien-
tists with many kinds of interests and expertise. 
These enriching meetings and their proceedings 
have forcefully affected the direction of dermato-
logic research and our understanding of the biology 
of the skin. This statement applies to all the 
symposia. Unfortunately, we can mention only a 
few of them as ill ustra tions. 
To appreciate the progress that resulted from 
these meetings, one need only reflect upon the 
discussions at some of the early symposia-on 
keratinization, on the hair follicles, on the seba-
ceous glands-and to compare these finding with 
those which were published ten, fifteen, and 
twenty years later. 
Again, the lively discussion of cell renewal in the 
epidermis during the Symposium on Wound Heal-
ing in 1963, stimulated a small group of investiga-
tors to adopt newer techniques to examine cell 
turnover in human skin. The series of reports 
which later appeared in the dermatologic literature 
culminated in a clearer concept of epidermal cell 
renewal, and this in turn led to the adoption of 
practical schedules for treating psoriasis with cyto-
toxic drugs. 
The anatomic discussions (unpublished) during 
the three symposia on the sebaceous glands re-
flected a growing comprehension of the pathogen-
esis of acne. Ebling's presentations in 1962, as well 
as Ebling [6] and Shuster and Thody's [7] spirited 
dialogue at the symposium ten years later, ad-
vanced our knowledge and guided our thinking on 
the subtle hormonal control of sebaceous glands, 
which has now been clearly summarized by Strauss 
in this volume. 
Earlier, we used the simile of the coral isle to 
typify the composite contributions of the numerous 
workers of the past. Like so many others, this 
simile is not exact. Each coral animal, we assume, 
contributes something fundamentally identical to 
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the contributions of all the others. In science, 
investigators make a wide variety of different kinds 
of contributions: minute details, precise measure-
ments and counts, morphologic descriptions, sta-
tistical evaluations, technical methods, grandiose 
hypotheses, iconoclastic hammers, organizational 
wizardry, inspirational leads, stimulating errors. 
Perhaps the most valuable contribution to even-
tual progress is the synthesis of many seemingly 
unrelated findings into single unifying concepts. 
This epilogue should serve as a prologue to all 
future symposia. Perhaps the best way to summa-
rize what we feel to be the urgency of scientific 
investigation is by repeating a story that one of 
us heard John Fitzgerald Kennedy tell in conclud-
ing his address on the hundredth birthday of the 
National Science Foundation. 
The great French field marshal, Louis Hubert 
Gonzalve Lyautey (1854-1934), aged and retired to 
his country home, called in his gardener one 
morning, handed him a sapling and told him to 
plant it in a certain spot in his garden the next day. 
"But, Marshal," said the gardener, "this tree 
will not bear fruit for another hundred years!" 
The old marshal smiled. "Did you say a hundred 
Vol. 67, No.1 
years? Well, then, we had better plant it this 
afternoon. " 
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